Literature DB >> 2296506

Childhood survival in Haiti: protective effect of measles vaccination.

E A Holt1, R Boulos, N A Halsey, L M Boulos, C Boulos.   

Abstract

To evaluate the impact of measles vaccination on survival of children residing in a periurban slum in Haiti, a total-population survey was conducted 2.5 years after completion of a one-time study of the serologic response to measles vaccine administered in the same population. Pregnancy histories from the 16,400 women in the population revealed that 1499 children had been born during a 7-month interval that would have made them eligible for participation in the measles vaccine program. Of these children, 1381 (92.1%) survived to 9 months of age, the median age that measles vaccine had been administered. Seventy-three infants had died between 9 and 39 months of age. Mortality of infants who were seronegative before receiving measles vaccine was significantly lower (P = .0013) than that of unvaccinated infants (3/235 vs 70/1056, respectively). Other factors positively associated with survival between 9 and 39 months of age included socioeconomic status (P = .0002), maternal literacy (P = .0020), maternal knowledge and use of oral rehydration solution (P = .0002), and an interval of greater than 24 months to the birth of the next younger sibling (P = .0012). Multivariate stepwise logistic regression analysis was used to evaluate the independent association of measles vaccination by adjusting for other factors that also correlated with survival and that might have been associated with maternal seeking of vaccinations.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2296506

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  17 in total

1.  Implication of vaccination on measles reduction and elimination in Nigeria.

Authors:  A B Onoja; K M Hamid; J A Adeniji; M D Mukhtar
Journal:  Afr J Med Med Sci       Date:  2014-09

2.  Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries.

Authors:  P Aaby; B Samb; F Simondon; A M Seck; K Knudsen; H Whittle
Journal:  BMJ       Date:  1995-08-19

Review 3.  Effectiveness of measles vaccination and vitamin A treatment.

Authors:  Christopher R Sudfeld; Ann Marie Navar; Neal A Halsey
Journal:  Int J Epidemiol       Date:  2010-04       Impact factor: 7.196

4.  Ideal age for measles vaccination with persisting maternal antibody, human immunodeficiency virus infection and protein-calorie malnutrition.

Authors:  S C Arya
Journal:  Infection       Date:  1993 Jul-Aug       Impact factor: 3.553

Review 5.  Measles control in developing and developed countries: the case for a two-dose policy.

Authors:  T H Tulchinsky; G M Ginsberg; Y Abed; M T Angeles; C Akukwe; J Bonn
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

6.  Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality.

Authors:  Michael J Mina; C Jessica E Metcalf; Rik L de Swart; A D M E Osterhaus; Bryan T Grenfell
Journal:  Science       Date:  2015-05-07       Impact factor: 47.728

Review 7.  Measles, mumps and rubella vaccine and heterologous immunity: a way out of the COVID-19 crisis?

Authors:  Jahnavi Shrivastava; Manish Narang; Sunil Gomber
Journal:  Sudan J Paediatr       Date:  2022

8.  Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial.

Authors:  Peter Aaby; Cesário L Martins; May-Lill Garly; Carlito Balé; Andreas Andersen; Amabelia Rodrigues; Henrik Ravn; Ida M Lisse; Christine S Benn; Hilton C Whittle
Journal:  BMJ       Date:  2010-11-30

9.  Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age.

Authors:  P Aaby; M Andersen; M Sodemann; M Jakobsen; J Gomes; M Fernandes
Journal:  BMJ       Date:  1993-11-20

10.  The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy.

Authors:  Peter Aaby; Cesário L Martins; May-Lill Garly; Amabelia Rodrigues; Christine S Benn; Hilton Whittle
Journal:  BMJ Open       Date:  2012-07-19       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.